Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 139
Filtrar
1.
Org Biomol Chem ; 20(4): 877-886, 2022 01 26.
Artigo em Inglês | MEDLINE | ID: mdl-35015006

RESUMO

Exo-ß-mannosidases are a broad class of stereochemically retaining hydrolases that are essential for the breakdown of complex carbohydrate substrates found in all kingdoms of life. Yet the detection of exo-ß-mannosidases in complex biological samples remains challenging, necessitating the development of new methodologies. Cyclophellitol and its analogues selectively label the catalytic nucleophiles of retaining glycoside hydrolases, making them valuable tool compounds. Furthermore, cyclophellitol can be readily redesigned to enable the incorporation of a detection tag, generating activity-based probes (ABPs) that can be used to detect and identify specific glycosidases in complex biological samples. Towards the development of ABPs for exo-ß-mannosidases, we present a concise synthesis of ß-manno-configured cyclophellitol, cyclophellitol aziridine, and N-alkyl cyclophellitol aziridines. We show that these probes covalently label exo-ß-mannosidases from GH families 2, 5, and 164. Structural studies of the resulting complexes support a canonical mechanism-based mode of action in which the active site nucleophile attacks the pseudoanomeric centre to form a stable ester linkage, mimicking the glycosyl enzyme intermediate. Furthermore, we demonstrate activity-based protein profiling using an N-alkyl aziridine derivative by specifically labelling MANBA in mouse kidney tissue. Together, these results show that synthetic manno-configured cyclophellitol analogues hold promise for detecting exo-ß-mannosidases in biological and biomedical research.


Assuntos
Cicloexanóis/química , Sondas Moleculares/química , beta-Manosidase/análise , Cicloexanóis/síntese química , Conformação Molecular , Sondas Moleculares/síntese química , beta-Manosidase/metabolismo
2.
Arch Pharm (Weinheim) ; 355(2): e2100362, 2022 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-34738656

RESUMO

Two independent chiral pool syntheses of both enantiomers of the TRPML inhibitor, trans-ML-SI3, were developed, starting from commercially available (1S,2R)- and (1R,2S)-configured cis-2-aminocyclohexanols. Both routes lead to the target compounds in excellent enantiomeric purity and good overall yields. For the most attractive (-)-trans-enantiomer, the R,R-configuration was identified by these unambiguous syntheses, and the results were confirmed by single-crystal X-ray structure analysis. These effective synthetic approaches further allow flexible variation of prominent residues in ML-SI3 for future in-depth analysis of structure-activity relationships as both the piperazine and the N-sulfonyl residues are introduced into the molecule at late stages of the synthesis.


Assuntos
Cicloexanóis/farmacologia , Canais de Potencial de Receptor Transitório/antagonistas & inibidores , Cicloexanóis/síntese química , Cicloexanóis/química , Estereoisomerismo , Relação Estrutura-Atividade
3.
J Med Chem ; 64(16): 11886-11903, 2021 08 26.
Artigo em Inglês | MEDLINE | ID: mdl-34355886

RESUMO

The PKC-θ isoform of protein kinase C is selectively expressed in T lymphocytes and plays an important role in the T cell antigen receptor (TCR)-triggered activation of mature T cells, T cell proliferation, and the subsequent release of cytokines such as interleukin-2 (IL-2). Herein, we report the synthesis and structure-activity relationship (SAR) of a novel series of PKC-θ inhibitors. Through a combination of structure-guided design and exploratory SAR, suitable replacements for the basic C4 amine of the original lead (3) were identified. Property-guided design enabled the identification of appropriately substituted C2 groups to afford potent analogs with metabolic stability and permeability to support in vivo testing. With exquisite general kinase selectivity, cellular inhibition of T cell activation as assessed by IL-2 expression, a favorable safety profile, and demonstrated in vivo efficacy in models of acute and chronic T cell activation with oral dosing, CC-90005 (57) was selected for clinical development.


Assuntos
Cicloexanóis/uso terapêutico , Doença Enxerto-Hospedeiro/tratamento farmacológico , Fatores Imunológicos/uso terapêutico , Proteína Quinase C-theta/antagonistas & inibidores , Inibidores de Proteínas Quinases/uso terapêutico , Pirimidinas/uso terapêutico , Animais , Células CACO-2 , Proliferação de Células/efeitos dos fármacos , Cicloexanóis/síntese química , Cicloexanóis/metabolismo , Humanos , Fatores Imunológicos/síntese química , Fatores Imunológicos/metabolismo , Ativação Linfocitária/efeitos dos fármacos , Masculino , Camundongos Endogâmicos C57BL , Simulação de Acoplamento Molecular , Estrutura Molecular , Ligação Proteica , Proteína Quinase C-delta/antagonistas & inibidores , Proteína Quinase C-delta/metabolismo , Proteína Quinase C-theta/metabolismo , Inibidores de Proteínas Quinases/síntese química , Inibidores de Proteínas Quinases/metabolismo , Pirimidinas/síntese química , Pirimidinas/metabolismo , Relação Estrutura-Atividade , Linfócitos T/efeitos dos fármacos
4.
Artigo em Inglês | MEDLINE | ID: mdl-33741446

RESUMO

More than 500 molecules have been identified as components of Cannabis sativa (C. sativa), of which the most studied is Δ9-tetrahydrocannabinol (Δ9-THC). Several studies have suggested that Δ9-THC exerts diverse biological effects, ranging from fragmentation of DNA to behavioral disruptions. Currently, it is accepted that most of the pharmacological properties of Δ9-THC engage the activation of the cannabinoid receptors, named CB1 and CB2. Interestingly, multiple pieces of evidence have suggested that the cannabinoid receptors play an active role in the modulation of several diseases leading to the design of synthetic cannabinoid-like compounds. Advances in the development of synthetic CB1 cannabinoid receptor selective agonists as therapeutical approaches are, however, limited. This review focuses on available evidence searched in PubMed regarding the synthetic CB1 cannabinoid receptor selective agonists such as AM-1235, arachidonyl-2' chloroethylamide (ACEA), CP 50,556-1 (Levonantradol), CP-55,940, HU-210, JWH-007, JWH-018, JWH-200 (WIN 55,225), methanandamide, nabilone, O-1812, UR-144, WIN 55,212-2, nabiximols, and dronabinol. Indeed, it would be ambitious to describe all available evidence related to the synthetic CB1 cannabinoid receptor selective agonists. However, and despite the positive evidence on the positive results of using these compounds in experimental models of health disturbances and preclinical trials, we discuss evidence in regards some concerns due to side effects.


Assuntos
Agonistas de Receptores de Canabinoides/síntese química , Agonistas de Receptores de Canabinoides/uso terapêutico , Substâncias Controladas/síntese química , Receptor CB1 de Canabinoide/agonistas , Analgésicos/síntese química , Analgésicos/uso terapêutico , Animais , Ansiolíticos/síntese química , Ansiolíticos/uso terapêutico , Canabinoides/síntese química , Canabinoides/uso terapêutico , Substâncias Controladas/administração & dosagem , Cicloexanóis/síntese química , Cicloexanóis/uso terapêutico , Dronabinol/análogos & derivados , Dronabinol/síntese química , Dronabinol/uso terapêutico , Humanos , Transtornos Mentais/tratamento farmacológico , Transtornos Mentais/metabolismo , Dor/tratamento farmacológico , Dor/metabolismo , Fenantridinas/síntese química , Fenantridinas/uso terapêutico , Receptor CB1 de Canabinoide/metabolismo
5.
J Med Chem ; 63(23): 14885-14904, 2020 12 10.
Artigo em Inglês | MEDLINE | ID: mdl-33258605

RESUMO

Overexpression of PIM 1, 2, and 3 kinases is frequently observed in many malignancies. Previously, we discovered a potent and selective pan-PIM kinase inhibitor, compound 2, currently in phase I clinical trials. In this work, we were interested in replacing the amino group on the cyclohexane ring in compound 2 with a hydroxyl group. Structure-based drug design led to cellularly potent but metabolically unstable tetra-substituted cyclohexyl diols. Efforts on the reduction of Log D by introducing polar heterocycles improved metabolic stability. Incorporating fluorine to the tetra-substituted cyclohexyl diol moiety further reduced Log D, resulting in compound 14, a cellularly potent tetra-substituted cyclohexyl diol inhibitor with moderate metabolic stability and good permeability. We also describe the development of efficient and scalable synthetic routes toward synthetically challenging tetra-substituted cyclohexyl diol compounds. In particular, intermediate 36 was identified as a versatile intermediate, enabling a large-scale synthesis of highly substituted cyclohexane derivatives.


Assuntos
Cicloexanóis/farmacologia , Inibidores de Proteínas Quinases/farmacologia , Proteínas Proto-Oncogênicas c-pim-1/antagonistas & inibidores , Linhagem Celular Tumoral , Cicloexanóis/síntese química , Cicloexanóis/metabolismo , Humanos , Microssomos Hepáticos/metabolismo , Simulação de Acoplamento Molecular , Estrutura Molecular , Ligação Proteica , Inibidores de Proteínas Quinases/síntese química , Inibidores de Proteínas Quinases/metabolismo , Proteínas Proto-Oncogênicas c-pim-1/metabolismo , Relação Estrutura-Atividade
6.
J Am Chem Soc ; 142(30): 13021-13029, 2020 07 29.
Artigo em Inglês | MEDLINE | ID: mdl-32605368

RESUMO

Golgi mannosidase II (GMII) catalyzes the sequential hydrolysis of two mannosyl residues from GlcNAcMan5GlcNAc2 to produce GlcNAcMan3GlcNAc2, the precursor for all complex N-glycans, including the branched N-glycans associated with cancer. Inhibitors of GMII are potential cancer therapeutics, but their usefulness is limited by off-target effects, which produce α-mannosidosis-like symptoms. Despite many structural and mechanistic studies of GMII, we still lack a potent and selective inhibitor of this enzyme. Here, we synthesized manno-epi-cyclophellitol epoxide and aziridines and demonstrate their covalent modification and time-dependent inhibition of GMII. Application of fluorescent manno-epi-cyclophellitol aziridine derivatives enabled activity-based protein profiling of α-mannosidases from both human cell lysate and mouse tissue extracts. Synthesized probes also facilitated a fluorescence polarization-based screen for dGMII inhibitors. We identified seven previously unknown inhibitors of GMII from a library of over 350 iminosugars and investigated their binding modalities through X-ray crystallography. Our results reveal previously unobserved inhibitor binding modes and promising scaffolds for the generation of selective GMII inhibitors.


Assuntos
Cicloexanóis/farmacologia , Descoberta de Drogas , Inibidores Enzimáticos/farmacologia , Manosidases/antagonistas & inibidores , Cicloexanóis/síntese química , Cicloexanóis/química , Inibidores Enzimáticos/síntese química , Inibidores Enzimáticos/química , Humanos , Manosidases/metabolismo , Estrutura Molecular
7.
Org Biomol Chem ; 17(24): 5951-5961, 2019 06 18.
Artigo em Inglês | MEDLINE | ID: mdl-31166343

RESUMO

The syntheses of conduramine B-2, ent-conduramine F-2, aminocyclopentitol and trihydroxyazepane were accomplished from a common precursor, through a divergent approach using ring closing metathesis (RCM) as the key step. Tri-O-benzyl-d-glucal was converted to 3,4,6-tri-O-benzyl-1,2-dideoxy-2-iodo-1-p-toluenesulfonamido-α-d-mannose. Exposure to NaBH4 in MeOH resulted in a facile 1,2-transposition of the -NHTs group with concomitant glycosylation to give methyl 3,4,6-tri-O-benzyl-2-deoxy-2-p-toluenesulfonamido-ß-d-glucoside, which was converted into methyl 6-deoxy-6-iodo-glucoside in three steps. Zinc-mediated Vasella's rearrangement proceeded smoothly to give the pluripotent formyl-olefin, possessing both electrophilic and nucleophilic sites, which was used as a common precursor in our diversity-oriented approach. Vinylation of the carbonyl group followed by RCM and subsequent deprotection resulted in the successful synthesis of conduramine B-2 and ent-conduramine F-2 for the first time. On the other hand, the Wittig reaction of the formyl-olefin affords the diene that undergoes Grubbs' I catalyzed RCM and deprotection/reduction to provide 3-amino-cyclopentan-1,2-diol. Utilizing the nucleophilic site at the nitrogen of the common precursor, base mediated N-allylation was carried out to obtain the corresponding diene that underwent a smooth RCM to afford trihydroxyazepane.


Assuntos
Azepinas/síntese química , Cicloexanóis/síntese química , Cicloexilaminas/síntese química , Ciclopentanos/síntese química , Azepinas/química , Cicloexanóis/química , Cicloexilaminas/química , Ciclopentanos/química , Glicosilação , Estrutura Molecular
8.
Neurotoxicology ; 73: 161-167, 2019 07.
Artigo em Inglês | MEDLINE | ID: mdl-30953678

RESUMO

A recent push to provide more translationally relevant preclinical models for examination of pharmacological mechanisms underlying inhaled substances of abuse has resulted in the development of equipment and methods that allows exposure of freely moving rodents to aerosolized psychoactive drugs. In the present study, synthetic cannabinoids (CP55,940, AB-CHMINACA, and AMB-FUBINACA) were administered intraperitoneally (i.p.) or aerosolized via a modified electronic cigarette device. Subsequently, the compounds were evaluated in adult male and female C57/Bl6 mice trained to discriminate i.p. 5.6 mg/kg Δ9-tetrahydrocannabinol (THC) for food reinforcement. When administered i.p., THC and AB-CHMINACA were equally potent at producing THC-like effects in both sexes, but CP55,940 and AMB-FUBINACA were more potent in males. Upon aerosol exposure, all compounds continued to produce THC-like effects in both sexes, with AMB-FUBINACA remaining the most potent. In contrast, aerosolized CP55,940 showed substantial decreases in potency in both sexes. Aerosolized nicotine did not substitute for THC in either sex. In females, aerosolized cumyl-4CN-BINACA produced concentration-dependent increases in responding on the THC-associated nosepoke. In addition, the effects of an active concentration of AMB-FUBINACA were reversed by rimonabant, suggesting CB1 receptor mediation. These results show that synthetic cannabinoids produce THC-like effects when injected i.p. or after aerosolization. This study adds to a growing literature suggesting that evaluation of abuse liability of substances via aerosol exposure is feasible and may provide a translationally relevant method that allows for investigation of factors important to the abuse of drugs which humans typically smoke or vape.


Assuntos
Comportamento Animal/efeitos dos fármacos , Canabinoides/administração & dosagem , Condicionamento Operante/efeitos dos fármacos , Cicloexanóis/administração & dosagem , Sistemas Eletrônicos de Liberação de Nicotina , Indazóis/administração & dosagem , Valina/análogos & derivados , Vaping , Administração por Inalação , Aerossóis , Animais , Canabinoides/síntese química , Cicloexanóis/síntese química , Feminino , Indazóis/síntese química , Injeções Intraperitoneais , Masculino , Camundongos Endogâmicos C57BL , Valina/administração & dosagem , Valina/síntese química
9.
J Med Chem ; 62(3): 1541-1561, 2019 02 14.
Artigo em Inglês | MEDLINE | ID: mdl-30633861

RESUMO

Our earliest phytochemical separation of Miliusa sinensis aided us in the isolation of a class of unique miliusanes, which were demonstrated as anticancer lead molecules. In the present study, we isolated 19 miliusanes (1-19), including 11 novel ones (5 and 10-19) from another Miliusa plant ( M. balansae), and synthesized additional derivatives to elucidate the structure-activity relationship of miliusanes. When extrapolated to various carcinoma xenograft mouse models, miliusol (1) and its derivatives 20, 26, and 27 (7.5-40 mg/kg) were demonstrated with tumor inhibitory efficacy comparable or even superior to the mainstay chemotherapeutics paclitaxel or fluorouracil. To gain a molecular insight into their anticancer mechanism, 1-3 (GI50 0.03-4.79) were administered to a wide spectrum of human cancer cell lines, including those with specific drug resistance. We further revealed that the antiproliferative properties of miliusanes in carcinoma cells were highly associated with the p21-dependent induction of cellular senescence.


Assuntos
Annonaceae/química , Antineoplásicos/farmacologia , Senescência Celular/efeitos dos fármacos , Cicloexanonas/farmacologia , Animais , Antineoplásicos/síntese química , Antineoplásicos/isolamento & purificação , Apoptose/efeitos dos fármacos , Linhagem Celular Tumoral , Inibidor de Quinase Dependente de Ciclina p21/metabolismo , Cicloexanóis/síntese química , Cicloexanóis/isolamento & purificação , Cicloexanóis/farmacologia , Cicloexanonas/síntese química , Cicloexanonas/isolamento & purificação , Feminino , Humanos , Masculino , Camundongos Endogâmicos BALB C , Estrutura Molecular , Transdução de Sinais/efeitos dos fármacos , Compostos de Espiro/síntese química , Compostos de Espiro/isolamento & purificação , Compostos de Espiro/farmacologia , Relação Estrutura-Atividade , Ensaios Antitumorais Modelo de Xenoenxerto
10.
Bioorg Med Chem ; 27(12): 2345-2367, 2019 06 15.
Artigo em Inglês | MEDLINE | ID: mdl-30606671

RESUMO

Novel carbohydrate mimics were designed which contain two 5a-carba-d-glucose residues, one each at reducing and nonreducing end, and thus these mimics are 5a,5a'-dicarba-d-glucobioses. Dicarbadisaccharides have attractive features such as stability against endogenous degradative enzymes and being resistant to glycation reactions such as the Maillard reaction. For the synthesis of dicarba-ß-d-isomaltose derivatives, the carbaglucosyl triflate locked in 4C1 conformation was synthesized by protecting with butane-2,3-diacetal group or benzylidene group. Then, 5a,5a'-dicarba-ß-d-maltose and 5a,5a'-dicarba-α,ß-d-trehalose were synthesized by the SN2-type inversion reaction using 4,6-O-benzylidene carbaglucosyl triflate with 4-OH and 1-OH carba-ß-d-glucose derivatives, respectively, and similarly 5a,5a'-dicarba-α-d-isomaltose with 6-OH carba-α-d-glucose derivative.


Assuntos
Cicloexanóis/síntese química , Dissacarídeos/síntese química , Mesilatos/química , Conformação Molecular
11.
Chemistry ; 25(7): 1722-1726, 2019 Feb 01.
Artigo em Inglês | MEDLINE | ID: mdl-30508325

RESUMO

The plant Psychotria kirkii hosts an obligatory bacterial symbiont, Candidatus Burkholderia kirkii, in nodules on their leaves. Recently, a glucosylated derivative of (+)-streptol, (+)-streptol glucoside, was isolated from the nodulated leaves and was found to possess a plant growth inhibitory activity. To establish a structure-activity relationship study, a convergent strategy was developed to obtain several pseudosugars from a single synthetic precursor. Furthermore, the glucosylation of streptol was investigated in detail and conditions affording specifically the α or ß glucosidic anomer were identified. Although (+)-streptol was the most active compound, its concentration in P. kirkii plant leaves extract was approximately ten-fold lower than that of (+)-streptol glucoside. These results provide compelling evidence that the glucosylation of (+)-streptol protects the plant host against the growth inhibitory effect of the compound, which might constitute a molecular cornerstone for this successful plant-bacteria symbiosis.


Assuntos
Burkholderia/isolamento & purificação , Cicloexanóis/química , Glucosídeos/química , Psychotria/metabolismo , Psychotria/microbiologia , Produtos Biológicos/síntese química , Produtos Biológicos/química , Produtos Biológicos/farmacologia , Burkholderia/crescimento & desenvolvimento , Cicloexanóis/síntese química , Cicloexanóis/farmacologia , Glucosídeos/síntese química , Glucosídeos/farmacologia , Glicosilação , Lactuca/crescimento & desenvolvimento , Folhas de Planta/metabolismo , Folhas de Planta/microbiologia , Plântula/efeitos dos fármacos , Plântula/crescimento & desenvolvimento , Estereoisomerismo , Relação Estrutura-Atividade , Simbiose
12.
J Org Chem ; 83(17): 10573-10579, 2018 09 07.
Artigo em Inglês | MEDLINE | ID: mdl-30080961

RESUMO

A flexible synthesis of the carbocyclic core present in glycosides xylosmin and flacourtosides E and F, natural products exhibiting antimalarial and antiarboviral activities, has been accomplished. Our approach emanates from the Diels-Alder adduct of cyclopentadiene and MOM-protected 2-hydroxymethyl- p-benzoquinone and takes advantage of the stereochemical propensity of the norbornyl-fused scaffolds to generate the dense oxy-functionalization pattern with stereocontrol, enroute to a racemic synthesis of the carbocyclic core present in the aforementioned bioactive materials. This effort augurs well for exploring chemical diversity space around their scaffold.


Assuntos
Cicloexanóis/química , Cicloexanóis/síntese química , Glicosídeos/química , Oxigênio/química , Fenóis/química , Técnicas de Química Sintética , Estereoisomerismo
13.
Molecules ; 23(7)2018 07 06.
Artigo em Inglês | MEDLINE | ID: mdl-29986401

RESUMO

An efficient and facile general method for the synthesis of conduritol C analogs, taking advantage of an enantioselective biocatalysis process of monosubstituted benzenes, is described. The absolute stereochemical patterns of the target molecules (−)-conduritol C, (−)-bromo-conduritol C, and (−)-methyl-conduritol C were achieved by means of chemoenzymatic methods. The stereochemistry present at the homochiral cyclohexadiene-cis-1,2-diols derived from the arene biotransformation and the enantioselective ring opening of a non-isolated vinylepoxide derivative permitted the absolute configuration of the carbon bearing the hydroxyl groups at the target molecules to be established. All three conduritols and two intermediates were crystallized, and their structures were confirmed by X-ray diffraction. The three conduritols and intermediates were isostructural. The versatility of our methodology is noteworthy to expand the preparation of conduritol C analogs starting from toluene dioxygenase (TDO) monosubstituted arene substrates.


Assuntos
Cicloexanóis/síntese química , Cicloexenos/síntese química , Biocatálise , Biotransformação , Cristalografia por Raios X , Cicloexanóis/química , Cicloexenos/química , Modelos Moleculares , Estrutura Molecular , Estereoisomerismo
14.
Bioorg Med Chem ; 26(12): 3096-3110, 2018 07 23.
Artigo em Inglês | MEDLINE | ID: mdl-29720349

RESUMO

Inhibition of the Hsp90 C-terminus is an attractive therapeutic approach for the treatment of cancer. Novobiocin, the first Hsp90 C-terminal inhibitor identified, contains a synthetically complex noviose sugar that has limited the generation of structure-activity relationships for this region of the molecule. The work described herein utilizes various ring systems as noviose surrogates to explore the size and nature of the surrounding binding pocket.


Assuntos
Proteínas de Choque Térmico HSP90/metabolismo , Compostos de Bifenilo/síntese química , Compostos de Bifenilo/química , Compostos de Bifenilo/farmacologia , Linhagem Celular Tumoral , Proliferação de Células/efeitos dos fármacos , Cicloexanóis/síntese química , Cicloexanóis/química , Cicloexanóis/farmacologia , Proteínas de Choque Térmico HSP90/antagonistas & inibidores , Humanos , Células MCF-7 , Novobiocina/síntese química , Novobiocina/química , Novobiocina/farmacologia , Piperidinas/síntese química , Piperidinas/química , Piperidinas/farmacologia , Domínios Proteicos , Relação Estrutura-Atividade
15.
Chemistry ; 23(51): 12604-12612, 2017 Sep 12.
Artigo em Inglês | MEDLINE | ID: mdl-28661578

RESUMO

The glmS ribozyme is a bacterial gene-regulating riboswitch that controls cell wall synthesis, depending on glucosamine-6-phosphate as a cofactor. Due to the presence of this ribozyme in several human pathogen bacteria (e.g., MRSA, VRSA), the glmS ribozyme represents an attractive target for the development of artificial cofactors. The substitution of the ring oxygen in carbohydrates by functionalized methylene groups leads to a new generation of glycomimetics that exploits distinct interaction possibilities with their target structure in biological systems. Herein, we describe the synthesis of mono-fluoro-modified carba variants of α-d-glucosamine and ß-l-idosamine. (5aR)-Fluoro-carba-α-d-glucosamine-6-phosphate is a synthetic mimic of the natural ligand of the glmS ribozyme and is capable of effectively addressing its unique self-cleavage mechanism. However, in contrast to what was expected, the activity is significantly decreased compared to its non-fluorinated analog. By combining self-cleavage assays with the Bacillus subtilis and Staphylococcus aureus glmS ribozyme and molecular docking studies, we provide a structure-activity relationship for fluorinated carba-sugars.


Assuntos
Proteínas de Bactérias/metabolismo , Carbaçúcares/metabolismo , RNA Catalítico/metabolismo , Bacillus subtilis/metabolismo , Proteínas de Bactérias/química , Sítios de Ligação , Carbaçúcares/síntese química , Carbaçúcares/química , Cicloexanóis/síntese química , Cicloexanóis/química , Cicloexanóis/metabolismo , Cicloexilaminas/síntese química , Cicloexilaminas/química , Cicloexilaminas/metabolismo , Halogenação , Conformação Molecular , Simulação de Acoplamento Molecular , Conformação de Ácido Nucleico , RNA Catalítico/química , Staphylococcus aureus/metabolismo , Estereoisomerismo , Relação Estrutura-Atividade
16.
J Med Chem ; 60(2): 681-694, 2017 01 26.
Artigo em Inglês | MEDLINE | ID: mdl-28055204

RESUMO

Our initial structure-activity relationship studies on 7-methoxy-4-morpholino-benzothiazole derivatives featured by aryloxy-2-methylpropanamide moieties at the 2-position led to identification of compound 25 as a potent and selective A2A adenosine receptor (A2AAdoR) antagonist with reasonable ADME and pharmacokinetic properties. However, poor intrinsic solubility and low to moderate oral bioavailability made this series unsuitable for further development. Further optimization using structure-based drug design approach resulted in discovery of potent and selective adenosine A2A receptor antagonists bearing substituted 1-methylcyclohexyl-carboxamide groups at position 2 of the benzothiazole scaffold and endowed with better solubility and oral bioavailability. Compounds 41 and 49 demonstrated a number of positive attributes with respect to in vitro ADME properties. Both compounds displayed good pharmacokinetic properties with 63% and 61% oral bioavailability, respectively, in rat. Further, compound 49 displayed oral efficacy in 6-OHDA lesioned rat model of Parkinson diseases.


Assuntos
Antagonistas do Receptor A2 de Adenosina/farmacologia , Benzotiazóis/farmacologia , Cicloexanóis/farmacologia , Receptor A2A de Adenosina/metabolismo , Antagonistas do Receptor A2 de Adenosina/síntese química , Antagonistas do Receptor A2 de Adenosina/farmacocinética , Administração Oral , Animais , Antiparkinsonianos/síntese química , Antiparkinsonianos/farmacocinética , Antiparkinsonianos/farmacologia , Benzotiazóis/síntese química , Benzotiazóis/farmacocinética , Cicloexanóis/síntese química , Cicloexanóis/farmacocinética , Desenho de Fármacos , Células HEK293 , Humanos , Levodopa/farmacologia , Masculino , Microssomos Hepáticos/metabolismo , Simulação de Acoplamento Molecular , Ratos Wistar , Relação Estrutura-Atividade
17.
Nat Chem ; 8(10): 922-8, 2016 10.
Artigo em Inglês | MEDLINE | ID: mdl-27657867

RESUMO

Aromatic hydrocarbons are some of the most elementary feedstock chemicals, produced annually on a million metric ton scale, and are used in the production of polymers, paints, agrochemicals and pharmaceuticals. Dearomatization reactions convert simple, readily available arenes into more complex molecules with broader potential utility, however, despite substantial progress and achievements in this field, there are relatively few methods for the dearomatization of simple arenes that also selectively introduce functionality. Here we describe a new dearomatization process that involves visible-light activation of small heteroatom-containing organic molecules-arenophiles-that results in their para-cycloaddition with a variety of aromatic compounds. The approach uses N-N-arenophiles to enable dearomative dihydroxylation and diaminodihydroxylation of simple arenes. This strategy provides direct and selective access to highly functionalized cyclohexenes and cyclohexadienes and is orthogonal to existing chemical and biological dearomatization processes. Finally, we demonstrate the synthetic utility of this strategy with the concise synthesis of several biologically active compounds and natural products.


Assuntos
Compostos Azo/química , Derivados de Benzeno/química , Cicloexanóis/síntese química , Reação de Cicloadição , Cicloexilaminas/síntese química , Hidroxilação , Luz , Estrutura Molecular , Fenóis/síntese química
18.
FEBS Lett ; 590(4): 461-8, 2016 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-26790390

RESUMO

Covalent, mechanism-based inhibitors of glycosidases are valuable probe molecules for visualizing enzyme activities in complex systems. We, here, describe the chemoenzymatic synthesis of 6-phospho-cyclophellitol and evaluate its behaviour as a mechanism-based inactivator of the Streptococcus pyogenes 6-phospho-ß-glucosidase from CAZy family GH1. We further present the three-dimensional structure of the inactivated enzyme, which reveals the constellation of active site residues responsible for the enzyme's specificity and confirms the covalent nature of the inactivation.


Assuntos
Cicloexanóis/síntese química , Inibidores Enzimáticos/síntese química , Glucosidases/antagonistas & inibidores , Sondas Moleculares/síntese química , Streptococcus pyogenes/enzimologia , Domínio Catalítico , Coenzimas/química , Cristalografia por Raios X , Cicloexanóis/química , Inibidores Enzimáticos/química , Glucosidases/química , Sondas Moleculares/química , Conformação Proteica
19.
Org Biomol Chem ; 14(1): 172-82, 2016 Jan 07.
Artigo em Inglês | MEDLINE | ID: mdl-26468867

RESUMO

The isomers of dibenzylamino-1-methylcyclohexan-1-ol and dibenzylamino-1-trifluoromethylcyclohexan-1-ol have been prepared. The stereochemistry of these compounds was unequivocally assigned through a combination of NMR spectroscopy and single crystal X-ray analysis. The cis-isomer of 3-N,N-dibenzylamino-1-trifluoromethylcyclohexanol and its derivatives display an unusual conformational behaviour in both solution-phase and the solid-state, where the amino group usually adopts an axial conformation.


Assuntos
Benzilaminas/síntese química , Cicloexanóis/síntese química , Benzilaminas/química , Cristalografia por Raios X , Cicloexanóis/química , Espectroscopia de Ressonância Magnética , Modelos Moleculares , Conformação Molecular , Estereoisomerismo
20.
Magn Reson Chem ; 54(4): 320-7, 2016 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-26661926

RESUMO

A novel phosphonium salt based on pyridoxine was synthesized. Conformational analysis of the compound in solution was performed using dynamic NMR experiments and calculations. The obtained results revealed some differences in the conformational transitions and the energy parameters of the conformational exchange of the studied compound in comparison to previously reported data for other phosphorus-containing pyridoxine derivatives. It was shown that increasing the substituent at the C-11 carbon leads to greater differences in the populations of stable states and the corresponding equilibrium energies. Copyright © 2015 John Wiley & Sons, Ltd.


Assuntos
Cicloexanóis/síntese química , Espectroscopia de Ressonância Magnética/métodos , Teoria Quântica , Cicloexanóis/química , Modelos Moleculares , Estereoisomerismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA